- Report
- November 2020
- 49 Pages
Global
€1274EUR$1,318USD£1,076GBP
- Drug Pipelines
- September 2019
- 114 Pages
Global
€9669EUR$10,000USD£8,161GBP
- Drug Pipelines
- September 2019
- 118 Pages
Global
€9669EUR$10,000USD£8,161GBP
- Drug Pipelines
- September 2019
- 65 Pages
Global
€9669EUR$10,000USD£8,161GBP
- Drug Pipelines
- March 2019
- 111 Pages
Global
€9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 19 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 16 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 27 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Drug Pipelines
- August 2018
- 37 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 16 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 25 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 20 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 22 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 48 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- August 2018
- 21 Pages
Global
From €9669EUR$10,000USD£8,161GBP
- Report
- May 2023
- 167 Pages
Global
From €2417EUR$2,500USD£2,040GBP
- Report
- March 2023
- 157 Pages
Global
From €2417EUR$2,500USD£2,040GBP
- Report
- March 2022
- 120 Pages
Global
From €2417EUR$2,500USD£2,040GBP
- Report
- August 2022
Global
From €1054EUR$1,090USD£890GBP
- Report
- August 2022
Global
From €1151EUR$1,190USD£971GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Lung Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat lung cancer. These drugs are used to treat both non-small cell and small cell lung cancer, the two most common types of lung cancer. The drugs are designed to target the cancer cells and stop them from growing and spreading. Common treatments include chemotherapy, targeted therapy, immunotherapy, and radiation therapy.
The Lung Cancer Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies such as Bristol-Myers Squibb, Merck, Pfizer, AstraZeneca, and Roche are all major players in the market. These companies are constantly researching and developing new drugs to treat lung cancer, as well as improving existing treatments.
In addition, there are many smaller companies that specialize in the development of new drugs for the treatment of lung cancer. These companies often collaborate with larger pharmaceutical companies to bring their drugs to market. Examples of these companies include ImmunoGen, Inc., Oncolytics Biotech, and ImmunoCellular Therapeutics. Show Less Read more